MKI67 and breast carcinoma: In a similar manner, and because immunohistochemistry results have been reported to vary with cold ischemia time34,35, we investigated the evolution of the protein expression of key markers in breast cancer including ER, PR, and KI67, leveraging a cohort of 33 samples kept at room temperature and 15 cooled samples.